2023
Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study
Das I, Yadav P, Andersen A, Chen Z, Huang L, Langer M, Lee C, Li L, Popple R, Rice R, Schiff P, Zhu T, Abazeed M. Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study. Radiotherapy And Oncology 2023, 182: 109571. PMID: 36822361, PMCID: PMC10121952, DOI: 10.1016/j.radonc.2023.109571.Peer-Reviewed Original ResearchConceptsDose prescriptionTreatment-related toxicityClinical outcome comparisonStereotactic body radiotherapyMulti-institutional studyTreatment guidelinesTreatment disparitiesBody radiotherapyPTV volumeClinical trialsTreatment protocolOutcome comparisonsTreatment efficacyAbstractTextHypofractionated treatmentDosimetric parametersDose parametersDosimetric variabilityDosimetric variationsStandardized reportingLack of standardization
2007
A Two-Stage IMRT Treatment Protocol Provides More Robust Radiotherapy for Prostate Cancer in Presence of Inter- and Intra-Fractional Organ Motions
Chen Z, Deng J, Nath R, Peschel R. A Two-Stage IMRT Treatment Protocol Provides More Robust Radiotherapy for Prostate Cancer in Presence of Inter- and Intra-Fractional Organ Motions. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s713-s714. DOI: 10.1016/j.ijrobp.2007.07.2100.Peer-Reviewed Original Research